Abstract

Deep learning has revolutionized medical imaging analysis, with YOLOv8 emerging as a promising tool forvarious tasks like lesion detection, organ segmentation and disease classification. This review investigates YOLOv8’sapplications across diverse medical imaging modalities (X-Ray, CT-Scan and MRI). We conducted a systematic literaturesearch across databases like Pubmed, ScienceDirect and IEEE to identify relevant studies evaluating YOLOv8’sperformance in medical imaging analysis. YOLOv8 achieved high performance for meningioma and pituitary tumorswith and without data augmentation (precision >0.92, recall >0.90, mAP >0.93). Glioma detection showed lowerperformance but still promising results (precision >0.86, recall >0.81, mAP >0.86). Breast cancer detection with SGDoptimizer yielded best performance with an average mAP of 0.87 for mass detection. The model achieved high accuracyin detecting normal (mAP 0.939) and malignant lesions (mAP 0.911). YOLO v8 on Dental radiograph successfullydetected cavities, impacted teeth, fillings and implants (precision of >0.82, recall of >0.78 and F1-Score of >0.80). Lastly,for lung disease classification, YOLOv8 achieved high accuracy (99.8% training and 90% validation) in classifyingnormal, COVID-19, influenza and lung cancer disease. With the importance to improve clinical decision-making andpatient outcomes in healthcare, the YOLOv8 algorthm underscores the importance of pre-processing, augmentation andoptimization of key hyperparameters.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.